EDGAR Filing Documents for 0000929638-24-002575

Form 3 - Initial statement of beneficial ownership of securities:

SEC Accession No. 0000929638-24-002575

Filing Date

2024-07-24

Accepted

2024-07-24 18:24:15

Documents

Period of Report

2024-07-22

Document Format Files

Seq	Description	Document	Type	Size
1		form3.html	3
1		form3.xml	3	1532
2	POWER OF ATTORNEY	exhibit24.htm	EX-24.1	4579
	Complete submission text file	0000929638-24-002575.txt		7575

Mailing Address C/O GENOCEA BIOSCIENCES, INC. 100 ACORN PARK DRIVE, 5TH FLOOR CAMBRIDGE MA 02140

Business Address

Cooper Ronald Harold Wilfred (Reporting) CIK: 0001676880 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41854 | Film No.: 241139241

Mailing Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1

Business Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1 (514) 332-4888

enGene Holdings Inc. (Issuer) CIK: 0001980845 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)